Andrea Scrima

Andrea Scrima

Auto-generated profile, based on publicly available information

Andrea Scrima

Department of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Straße 4a, Dortmund, Germany, 44227

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2021 in Advanced Science
Verified
Journal Article
Open access
PDF file
CSChristian Schütz
Christian Schütz
DHDuy‐Khiet Ho
Duy‐Khiet Ho
MHMostafa Mohamed Hamed
Mostafa Mohamed Hamed
AAAhmed Saad Abdelsamie
Ahmed Saad Abdelsamie
TRTeresa Röhrig
Teresa Röhrig
MEMartin Empting
Martin Empting
Pseudomonas aeruginosa (PA) infections can be notoriously difficult to treat and are often accompanied by the development of antimicrobial resistance (AMR). Quorum sensing inhibitors (QSI) acting on PqsR (MvfR) – a crucial transcriptional regulator serving major functions in PA virulence – can enhance antibiotic efficacy and eventually prevent the AMR. An integrated drug discovery campaign including design, medicinal chemistry‐driven hit‐to‐lead optimization and in‐depth biological profiling of a new QSI generation is reported. The QSI possess excellent activity in inhibiting pyocyanin production and PqsR reporter‐gene with IC50 values as low as 200 and 11 × 10−9 m, respectively. Drug metabolism and pharmacokinetics (DMPK) as well as safety pharmacology studies especially highlight the promising translational properties of the lead QSI for pulmonary applications. Moreover, target engagement of the lead QSI is shown in a PA mucoid lung infection mouse model. Beyond that, a significant synergistic effect of a QSI‐tobramycin (Tob) combination against PA biofilms using a tailor‐made squalene‐derived nanoparticle (NP) formulation, which enhance the minimum biofilm eradicating concentration (MBEC) of Tob more than 32‐fold is demonstrated. The novel lead QSI and the accompanying NP formulation highlight the potential of adjunctive pathoblocker‐mediated therapy against PA infections opening up avenues for preclinical development.

1 December 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CSChristian Schütz
Christian Schütz
AHAmir Hodzic
Amir Hodzic
MHMostafa M. Hamed
Mostafa M. Hamed
AAAhmed S. Abdelsamie
Ahmed S. Abdelsamie
AKAndreas M. Kany
Andreas M. Kany
MEMartin Empting
Martin Empting

23 September 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
VKVanessa Knittel
Vanessa Knittel
PSPooja Sadana
Pooja Sadana
SSStephanie Seekircher
Stephanie Seekircher
ASAnne-Sophie Stolle
Anne-Sophie Stolle
BKBritta Körner
Britta Körner
PDPetra Dersch
Petra Dersch
Type VI secretion systems (T6SSs) are complex macromolecular injection machines which are widespread in Gram-negative bacteria. They are involved in host-cell interactions and pathogenesis, required to eliminate competing bacteria, or are important for the adaptation to environmental stress conditions. Here we identified regulatory elements controlling the T6SS4 of Yersinia pseudotuberculosis and found a novel type of hexameric transcription factor, RovC. RovC directly interacts with the T6SS4 promoter region and activates T6SS4 transcription alone or in cooperation with the LysR-type regulator RovM. A higher complexity of regulation was achieved by the nutrient-responsive global regulator CsrA, which controls rovC expression on the transcriptional and post-transcriptional level. In summary, our work unveils a central mechanism in which RovC, a novel key activator, orchestrates the expression of the T6SS weapons together with a global regulator to deploy the system in response to the availability of nutrients in the species' native environment. A unique feature of type VI secretion systems is that several pathogenic bacteria encode multiple clusters for evolutionary distinct T6SSs, which presumably play a different role in their lifestyle. Some are necessary during infection for full virulence towards mammalian hosts, whereas others are needed for resistance to a broad range of adverse stresses and/or interbacterial competition in multibacterial communities by delivering bacteriolytic effectors into competing bacterial cells. Here we provide new insights into the control factors and regulatory circuits involved in a T6SS of Yersinia, which is activated under certain conditions to promote persistence and interbacterial competition in encountered host or environmental niches. Specifically, we identified a novel type of transcriptional activator that is able to induce T6SS expression. Based on the complex regulatory network, which fine-tunes its expression, it appears that this regulatory device has evolved as a switch that allows the rapid production of the T6SS apparatus only whenever it is needed during their environmental and host-associated lifestyle.

21 June 2024 in Science Advances
Verified
Journal Article
Open access
MKMegha N. Karanth
Megha N. Karanth
JKJohn P. Kirkpatrick
John P. Kirkpatrick
JKJoern Krausze
Joern Krausze
SSStefan Schmelz
Stefan Schmelz
ASAndrea Scrima
Andrea Scrima
TCTeresa Carlomagno
Teresa Carlomagno
In the quest for new bioactive substances, nonribosomal peptide synthetases (NRPS) provide biodiversity by synthesizing nonproteinaceous peptides with high cellular activity. NRPS machinery consists of multiple modules, each catalyzing a unique series of chemical reactions. Incomplete understanding of the biophysical principles orchestrating these reaction arrays limits the exploitation of NRPSs in synthetic biology. Here, we use nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry to solve the conundrum of how intermodular recognition is coupled with loaded carrier protein specificity in the tomaymycin NRPS. We discover an adaptor domain that directly recruits the loaded carrier protein from the initiation module to the elongation module and reveal its mechanism of action. The adaptor domain of the type found here has specificity rules that could potentially be exploited in the design of engineered NRPS machinery.

7 September 2026 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
GDGiovanni Danilo D'ANgelo
Giovanni Danilo D'ANgelo
KPKosmas Alexandros Pervanidis
Kosmas Alexandros Pervanidis
IAIoannis Athanasiadis
Ioannis Athanasiadis
VLVladimir Lukianchikov
Vladimir Lukianchikov
ASAndrea Scrima
Andrea Scrima
DRDaniel Rauh
Daniel Rauh

29 September 2026 in ACS Chemical Biology
Verified
Journal Article
Closed access
KPKosmas Alexandros Pervanidis
Kosmas Alexandros Pervanidis
GDGiovanni Danilo D’ANgelo
Giovanni Danilo D’ANgelo
IAIoannis Athanasiadis
Ioannis Athanasiadis
HJHannah Jantzen
Hannah Jantzen
ASAndrea Scrima
Andrea Scrima
DRDaniel Rauh
Daniel Rauh